Descriptions of NTP Study Types
Table 1. Comparison of results between the NCI/NTP 2 yearbioassay in B6C3F1 mice and in 24 week studiesa in heterozygous p53 (+/-)deficient (C57BL/6) mice.
B6C3F1 | p53def | ||||
---|---|---|---|---|---|
Chemical | TR No. | SALb | Route | Target Organ | Results |
p-Anisidine | 115 | + | Feed | None | - |
Benzene | 289 | -c; +d | Gavage | Multiple Sites | + |
p-Cresidine | 142 | + | Feed | Bladder, Liver | + |
4-Vinyl-1-cyclohexene diepoxide | 362 | + | Skin Paint | Skin, Ovary | + |
N-Methyl-o-acrylamide | 352 | - | Gavage | Kidney, Liver | - |
Reserpine | 193 | - | Feed | Mammary | - |
a
Replication of the NCI/NTP 2 year bioassay using the same route of
administration and dose range.
b In vitro Salmonella mutagenesis assay
c In vitro Salmonella mutagenesis assay negative
d In vivo micronucleus assay positive
Web page last updated on June 09, 2005